Counselors in Yauco, PR Accepting Medicare

9 Counselors found. Showing 1 - 9

Marybel Ramos Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: Estancias De Yauco Esmeralda C6, Yauco, PR 00698 Phone: 787-399-2336    Fax: 787-844-4130

Mrs. Michelle Febles Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: Condominio Las Torres De Navel, Apartamento 301 A, Yauco, PR 00698 Phone: 787-673-1382

Anadoris Estrada Torres Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: Inspira Yauco 55 Calle Comercio, Yauco, PR 00698 Phone: 787-704-0705

Glenda Y Camacho Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: Hc 1 Box 6132, Yauco, PR 00698 Phone: 939-247-6112    Fax: 787-844-4130

Melgrid Olmeda Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 20 Calle Prol 25 De Julio Apt 402b, Yauco, PR 00698 Phone: 689-227-9681

Mrs. Nilsa Velez, M.S.W. Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: Hc 4 Box 11575, Yauco, PR 00698 Phone: 939-272-2384

Prof. Johnny Cintron Jr., LPC Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 108 Calle Saturno, Urb Vistas De Monte Sol, Yauco, PR 00698 Phone: 787-217-6784

Mrs. Ada A Ruiz Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: Bo Susua Baja Sector Las Pelas, Yauco, PR 00698 Phone: 787-989-2358

Mrs. Ana I Maldonado Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: Hc 2 Box 10523, Yauco, PR 00698 Phone: 787-543-1454

News Archive

Bursting common myths about psoriasis

Psoriasis is a real disability that affects approximately one million Canadians. A recent Canadian survey found that the causes and effects of this chronic, recurrent skin disorder are often misunderstood - and the result of these misperceptions can leave a lasting negative impact on those who suffer from this debilitating immune system disease.

New study documents symptoms of people before they acquire multiple sclerosis

During the five years before people develop the first clinically recognized signs of multiple sclerosis, they are up to four times more likely to be treated for nervous system disorders such as pain or sleep problems, and are 50 per cent more likely to visit a psychiatrist, according to new research from the University of British Columbia.

NHC applauds IOM for recommendations on how to develop EHB package

The National Health Council (NHC) applauded the Institute of Medicine (IOM) for its thoughtful recommendations to the Secretary of Health and Human Services (HHS) on how to develop an essential health benefits (EHB) package.

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.

Flavor bans multiply, but menthol continues to divide

As states and communities rush to ban the sale of flavored tobacco products linked to vaping, Carol McGruder races from town to town, urging officials to include what she calls "the mother lode of all flavors": menthol.

Read more Medical News

› Verified 9 days ago